Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 01, 2022 08:00 ET | Source: PainReform Ltd

PainReform to Present at the H.C. Wainwright 24th Annual Global Investment Conference

TEL AVIV, Israel, Sept. 01, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of...
August 16, 2022 08:05 ET | Source: PainReform Ltd

PainReform Provides Business Update for the Second Quarter of 2022

On track to commence Phase 3 clinical trial in bunionectomy in the fourth quarter of 2022 Completes tech transfer to CMO for manufacturing of clinical batches TEL AVIV, Israel, Aug. 16, 2022 ...
August 16, 2022 08:00 ET | Source: PainReform Ltd

PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification

TEL AVIV, Israel, Aug. 16, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical-stage specialty pharmaceutical company focused on the reformulation of...
May 17, 2022 07:00 ET | Source: PainReform Ltd

PainReform Provides Business Update for the First Quarter of 2022

TEL AVIV, Israel, May 17, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of...
April 12, 2022 09:00 ET | Source: PainReform Ltd

PainReform to Present at The Noble Capital Markets' Eighteenth Annual Investor Conference on April 20th

TEL AVIV, Israel, April 12, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today...
March 21, 2022 09:25 ET | Source: PainReform Ltd

PainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th

TEL AVIV, Israel, March 21, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of...
March 17, 2022 08:00 ET | Source: PainReform Ltd

PainReform Provides Year-End Business Update; on Track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022

TEL AVIV, Israel, March 17, 2022 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of...
December 14, 2021 08:30 ET | Source: PainReform Ltd

PainReform CEO to Participate in the Benzinga All Access Event on December 16th

TEL AVIV, Israel, Dec. 14, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of...
November 16, 2021 08:00 ET | Source: PainReform Ltd

PainReform Provides Business Update for the Third Quarter of 2021

Reports continued progress towards commencing Phase 3 clinical trials Announces Selection of Pharmaceutics International, Inc. as U.S. Manufacturer of PRF-110 for Upcoming Phase 3 Trial TEL AVIV,...
October 14, 2021 08:30 ET | Source: PainReform Ltd

PainReform to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021

TEL AVIV, Israel, Oct. 14, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of...